01526 瑞慈醫療
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
03/01/2025Chelsea Grace Holdings Limited1316(L)12,752,400(L)971,389,200(L)
0(S)
0(P)
61.08
0.00
0.00
03/01/2025方宜新1316(L)12,752,400(L)1,003,196,200(L)
0(S)
63.08
0.00
03/01/2025梅红1316(L)12,752,400(L)1,003,196,200(L)
0(S)
63.08
0.00
19/12/2024梅红1101(L)+12,752,400(L)1,003,196,200(L)
0(S)
63.08
0.00
19/12/2024Chelsea Grace Holdings Limited1101(L)+12,752,400(L)971,389,200(L)
0(S)
0(P)
61.08
0.00
0.00
19/12/2024方宜新1113(L)+12,752,400(L)1,003,196,200(L)
0(S)
63.08
0.00
24/01/2024Chelsea Grace Holdings Limited1201(L)
1201(S)
-78,000,000(L)
-78,000,000(S)
1,062,836,800(L)
104,200,000(S)
0(P)
66.83
6.55
0.00
24/01/2024Chelsea Grace Holdings Limited1201(L)
1201(S)
-74,200,000(L)
-74,200,000(S)
958,636,800(L)
0(S)
0(P)
60.28
0.00
0.00
24/01/2024方宜新1201(L)
1201(S)
-74,200,000(L)
-74,200,000(S)
990,443,800(L)
0(S)
62.28
0.00
24/01/2024梅红1201(L)
1201(S)
-74,200,000(L)
-74,200,000(S)
990,443,800(L)
0(S)
62.28
0.00
24/01/2024方宜新1201(L)
1201(S)
-78,000,000(L)
-78,000,000(S)
1,094,643,800(L)
104,200,000(S)
68.83
6.55
24/01/2024Chelsea Grace Holdings Limited1201(L)
1201(S)
-30,000,000(L)
-30,000,000(S)
1,032,836,800(L)
74,200,000(S)
0(P)
64.95
4.67
0.00
24/01/2024方宜新1201(L)
1201(S)
-30,000,000(L)
-30,000,000(S)
1,064,643,800(L)
74,200,000(S)
66.95
4.67
24/01/2024梅红1201(L)
1201(S)
-78,000,000(L)
-78,000,000(S)
1,094,643,800(L)
104,200,000(S)
68.83
6.55
24/01/2024梅红1201(L)
1201(S)
-30,000,000(L)
-30,000,000(S)
1,064,643,800(L)
74,200,000(S)
66.95
4.67
08/01/2024方宜新1302(L)
1302(S)
30,000,000(L)
+30,000,000(S)
1,172,643,800(L)
108,000,000(S)
73.74
6.79
08/01/2024Chelsea Grace Holdings Limited1302(L)
1302(S)
74,200,000(L)
+74,200,000(S)
1,140,836,800(L)
182,200,000(S)
0(P)
71.74
11.46
0.00
08/01/2024方宜新1302(L)
1302(S)
74,200,000(L)
+74,200,000(S)
1,172,643,800(L)
182,200,000(S)
73.74
11.46
08/01/2024方宜新1302(L)
1302(S)
78,000,000(L)
+78,000,000(S)
1,172,643,800(L)
78,000,000(S)
73.74
4.90
08/01/2024梅红1302(L)
1302(S)
74,200,000(L)
+74,200,000(S)
1,172,643,800(L)
182,200,000(S)
73.74
11.46
08/01/2024Chelsea Grace Holdings Limited1302(L)
1302(S)
30,000,000(L)
+30,000,000(S)
1,140,836,800(L)
108,000,000(S)
0(P)
71.74
6.79
0.00
08/01/2024Chelsea Grace Holdings Limited1302(L)
1302(S)
78,000,000(L)
+78,000,000(S)
1,140,836,800(L)
78,000,000(S)
0(P)
71.74
4.90
0.00
08/01/2024梅红1302(L)
1302(S)
78,000,000(L)
+78,000,000(S)
1,172,643,800(L)
78,000,000(S)
73.74
4.90
08/01/2024梅红1302(L)
1302(S)
30,000,000(L)
+30,000,000(S)
1,172,643,800(L)
108,000,000(S)
73.74
6.79
21/12/2023梅红1316(L)268,286,800(L)1,172,643,800(L)73.74
21/12/2023BPEA EQT Holdings AB1704(L)-268,286,800(L)0(L)0.00
21/12/2023BPEA Private Equity GP V, L.P.1704(L)-268,286,800(L)0(L)0.00
21/12/2023BPEA Private Equity GP V Limited1704(L)-268,286,800(L)0(L)0.00
21/12/2023Chelsea Grace Holdings Limited1316(L)268,286,800(L)1,140,836,800(L)71.74
21/12/2023BPEA Private Equity Fund V, L.P.1704(L)-268,286,800(L)0(L)0.00
21/12/2023Renaissance Healthcare Holdings Limited1704(L)-268,286,800(L)0(L)0.00
21/12/2023EQT AB1704(L)-268,286,800(L)0(L)0.00
21/12/2023方宜新1316(L)268,286,800(L)1,172,643,800(L)73.74
26/10/2023方宜新1113(L)+268,286,800(L)1,172,643,800(L)
0(S)
73.74
0.00
26/10/2023BPEA Private Equity Fund V, L.P.1302(L)268,286,800(L)268,286,800(L)16.87
26/10/2023BPEA Private Equity GP V Limited1302(L)268,286,800(L)268,286,800(L)16.87
26/10/2023BPEA Private Equity GP V, L.P.1302(L)268,286,800(L)268,286,800(L)16.87
26/10/2023EQT AB1302(L)268,286,800(L)268,286,800(L)16.87
26/10/2023BPEA EQT Holdings AB1302(L)268,286,800(L)268,286,800(L)16.87
26/10/2023Chelsea Grace Holdings Limited1101(L)+268,286,800(L)1,140,836,800(L)
0(S)
0(P)
71.74
0.00
0.00
 1    2  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.